skip to the content

 

RoActemra (tocilizumab)

Treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients, treatment of active systemic juvenile idiopathic arthritis (sJIA) and juvenile idiopathic polyarthritis (rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older.

(This is a brief indication for use; for details see SPC) 

SPC - RoActemra 20mg/ml Concentrate for Solution for Infusion
PIL – RoActemra 20mg/ml Concentrate for Solution for Infusion

SPC - RoActemra 162mg/ml for Solution for Injection in pre-filled syringe
PIL – RoActemra 162mg/ml for Solution for Injection in pre-filled syringe

RoActemra information at Medicine Guides